|
128 Companies |
|
121 Products |
|
121 Products |
|
104 Mechanisms of Action |
|
7 Trials |
|
1812 News |
|
| «12...2021222324252627282930...3637» |
- Trial completion: Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists (clinicaltrials.gov) - Apr 3, 2014
P=N/A, N=21, Completed, Sponsor: Chuncheon Sacred Heart Hospital
Enrolling by invitation --> Completed
- Biomarker, Enrollment open: Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management (clinicaltrials.gov) - Apr 2, 2014
P=N/A, N=100, Enrolling by invitation, Sponsor: University of North Carolina, Chapel Hill
Enrolling by invitation --> Completed Not yet recruiting --> Enrolling by invitation
- Enrollment open: SWAMECO: Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=50, Recruiting, Sponsor: Kurt Hersberger
Not yet recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
- Trial completion: The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients (clinicaltrials.gov) - Mar 29, 2014
P=N/A, N=95, Completed, Sponsor: Shanghai Zhongshan Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- Cytology: Esophageal Cytology With FISH in Detecting Esophageal Cancer (clinicaltrials.gov) - Mar 27, 2014
P=N/A, N=310, Recruiting, Sponsor: OHSU Knight Cancer Institute
- | cendakimab (CC-93538) / AbbVie, BMS
New P2 trial: HEROES: Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis (clinicaltrials.gov) - Mar 26, 2014
P2, N=90, Not yet recruiting, Sponsor: Receptos, Inc.
- ||| esomeprazole / Generic mfg.
Trial completion: Nexium Capsules Clinical Experience Investigation (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=3691, Completed, Sponsor: AstraZeneca
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Enrollment open: Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy (clinicaltrials.gov) - Mar 24, 2014
P=N/A, N=100, Recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Dexilant (dexlansoprazole) / Takeda
New P1 trial: Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets (clinicaltrials.gov) - Mar 24, 2014
P1, N=8, Completed, Sponsor: Takeda
- Trial termination: A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1 (clinicaltrials.gov) - Mar 23, 2014
P0, N=67, Terminated, Sponsor: Anandasabapathy, Sharmila, M.D.
Recruiting --> Terminated; Low/no enrollment. No subjects were enrolled over the past year.
- Enrollment change: A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1 (clinicaltrials.gov) - Mar 23, 2014
P0, N=67, Terminated, Sponsor: Anandasabapathy, Sharmila, M.D.
No subjects were enrolled over the past year. N=200 --> 67
- Dexilant (dexlansoprazole) / Takeda
Trial completion: Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets (clinicaltrials.gov) - Mar 20, 2014
P1, N=8, Completed, Sponsor: Takeda
N=200 --> 67 Not yet recruiting --> Completed
- Clinical: Endoscopic Screening on Esophageal Cancer (clinicaltrials.gov) - Mar 19, 2014
P=N/A, N=45386, Completed, Sponsor: Chinese Academy of Medical Sciences
- |||| colesevelam (IW-3718) / Ironwood Pharma
Enrollment open: Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors (clinicaltrials.gov) - Mar 12, 2014
P2, N=90, Recruiting, Sponsor: Ironwood Pharmaceuticals, Inc.
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- | New P2 trial: Pneumatic Dilatation or Surgical Myotomy for Achalasia (clinicaltrials.gov) - Mar 11, 2014
P2, N=56, Completed, Sponsor: Karolinska University Hospital
- Clinical: Pilot Study of Efficacy of Mechanical Insufflation Exsufflation in Stroke (clinicaltrials.gov) - Mar 4, 2014
P=N/A, N=10, Recruiting, Sponsor: The Catholic University of Korea
- ||| MM 111 / Elevation Oncology
Enrollment change, Metastases: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach (clinicaltrials.gov) - Mar 3, 2014
P2, N=120, Recruiting, Sponsor: Merrimack Pharmaceuticals
Not yet recruiting --> Recruiting N=180 --> 120
- Reflex: Gastric Microperfusion in Patients Undergoing Gastroesophageal Resections (clinicaltrials.gov) - Mar 2, 2014
P=N/A, N=50, Recruiting, Sponsor: Rigshospitalet, Denmark
- 5-fluorouracil / Generic mfg., cisplatin / Generic mfg.
Trial completion, Surgery, Metastases: Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery (clinicaltrials.gov) - Mar 2, 2014
P3, N=40, Completed, Sponsor: Federation Francophone de Cancerologie Digestive
N=180 --> 120 Active, not recruiting --> Completed
- Photofrin (porfimer sodium) / Advanz Pharma
Trial withdrawal: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light (clinicaltrials.gov) - Feb 27, 2014
P2, N=0, Withdrawn, Sponsor: Pinnacle Biologics Inc.
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Photofrin (porfimer sodium) / Advanz Pharma
Enrollment change: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light (clinicaltrials.gov) - Feb 27, 2014
P2, N=0, Withdrawn, Sponsor: Pinnacle Biologics Inc.
Not yet recruiting --> Withdrawn N=20 --> 0
- | New P2 trial: Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer (clinicaltrials.gov) - Feb 27, 2014
P2, N=80, Recruiting, Sponsor: Barretos Cancer Hospital
- | ranitidine hydrochloride / Generic mfg.
Trial completion: Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants (clinicaltrials.gov) - Feb 22, 2014
P3, N=18, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=20 --> 0 Recruiting --> Completed
- | Trial completion: Medical and Surgical Treatment of Esophageal Reflux (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=175, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting --> Completed No longer recruiting --> Completed
- | matuzumab (EMD 72000) / Takeda, EMD Serono
Trial completion, Combination therapy, Metastases: EMD 72000-024: Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=26, Completed, Sponsor: Merck KGaA
No longer recruiting --> Completed No longer recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=47, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Triapine (3-AP) / Vion, Northwestern University
Trial completion, Combination therapy, Metastases: 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction (clinicaltrials.gov) - Feb 22, 2014
P2, N=39, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg.
Trial completion, Metastases: Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | esomeprazole / Generic mfg.
Trial completion: Study of Acid Reflux in Asthma (clinicaltrials.gov) - Feb 22, 2014
P3, N=403, Completed, Sponsor: Johns Hopkins Bloomberg School of Public Health
Active, not recruiting --> Completed Recruiting --> Completed
- | carboplatin / Generic mfg., paclitaxel / Generic mfg., celecoxib oral / Generic mfg.
Trial completion: Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus (clinicaltrials.gov) - Feb 22, 2014
P2, N=39, Completed, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=11, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=204, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting --> Completed No longer recruiting --> Completed
- TNFerade (golnerminogene pradenovec) / Precigen
Trial completion, Gene therapy, Metastases: Study of TNFerade (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: GenVec
No longer recruiting --> Completed Active, not recruiting --> Completed
- | erlotinib / Generic mfg.
Trial completion, Metastases: Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg., irinotecan / Generic mfg.
Trial completion, Surgery: Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=97, Completed, Sponsor: Eastern Cooperative Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | erlotinib / Generic mfg.
Trial completion, Metastases: SWOG-S0127: Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | cisplatin / Generic mfg., irinotecan / Generic mfg.
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | erlotinib / Generic mfg.
Trial completion: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (clinicaltrials.gov) - Feb 22, 2014
P1, N=75, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Suspended --> Completed
- exatecan mesylate (DX-8951f) / Daiichi Sankyo
Trial completion, Metastases: DX-8951f in Treating Patients With Metastatic Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Daiichi Sankyo Inc.
Suspended --> Completed Suspended --> Completed
- | liposome encapsulated paclitaxel (LEP-ETU) / Insys Therap
Trial completion, Metastases: PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Suspended --> Completed Active, not recruiting --> Completed
- | Trial completion: Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | alvocidib (DSP-2033) / Sumitomo Pharma
Trial completion, Metastases: Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Suspended --> Completed
- | paclitaxel / Generic mfg.
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=37, Completed, Sponsor: M.D. Anderson Cancer Center
Suspended --> Completed Active, not recruiting --> Completed
- | Trial completion, Surgery, Metastases: Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg.
Trial completion, Combination therapy: Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Albany Medical College
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | uridine triacetate (PN 401) / Wellstat
Trial completion, Metastases: S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach (clinicaltrials.gov) - Feb 19, 2014
P2, N=65, Completed, Sponsor: Southwest Oncology Group
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Herceptin (trastuzumab) / Roche
Trial completion: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (clinicaltrials.gov) - Feb 19, 2014
P1, N=15, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | carboplatin / Generic mfg., docetaxel / Generic mfg.
Trial completion, Metastases: Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | oxaliplatin / Generic mfg., irinotecan / Generic mfg.
Trial completion, Metastases: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=36, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed